← Eichor
Study identifier: NCT06471127 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Neuroplasticity Biomarkers in Aphasia

Condition: Aphasia · Language · Stroke  ·  Sponsor: University of Wisconsin, Madison

PhaseNA
Planned participants90
Who can joinAll sexes, 40 Years to 90 Years
Healthy volunteersNo

About this study

Patients with stroke frequently suffer from aphasia, a disorder of expressive and/or receptive language, that can lead to serious health consequences, including social isolation, depression, reduced quality of life, and increased caregiver burden. Aphasia recovery varies greatly between individuals, and likely relies upon the capacity for neuroplasticity, both at a systems level of reorganized brain networks and a molecular level of neuronal repair and plasticity. The proposed work will evaluate genetic and neural network biological markers of neuroplasticity associated with variability in aphasia, with a future goal to improve prognostics and identify therapeutic targets to reduce the long-term burdens of aphasia.

This description comes directly from the study's public registry record.

Talk to the study team

Haley Dresang, PhD  ·  (608) 890-0628  ·  hdresang@wisc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UW School of Medicine and Public HealthMadison, Wisconsin, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06471127